@andreasroder1

Professor of Urology, @Rigshospitalet, @uni_copenhagen

 København, Danmark
Joined January 2022
  • Tweets587
  • Following344
  • Followers375
39Media
🧬 #BRCA 1/2 & #ProstateCancer: Our study finds 8x higher risk in men with BRCA1/2 than general population! 🔹 Low PSA thresholds > early detection 🔹 High Bx rates 🔹 Higher than expected rec risk despite low grade Dx @andreasroder1 @UrologicalRunit bit.ly/3WBbddu

Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants

Prostate Cancer and Prostatic Diseases - Prostate-specific antigen screening at low thresholds of men with pathogenic BRCA1/2 variants

nature.com
2
4
15
880
Significant reduction in PCa-mortality for men with newly diagnosed metastatic disease with Tx intensification on national scale in 🇩🇰. However, still many fragile old men who only get mono therapy. Kudos @HeinStroomberg @signebenzon @THelgstrand ejcancer.com/article/S0959-8…

Epidemiology of men with synchronous metastatic prostate cancer diagnosis – A nationwide 26-year...

The improved survival suggests that, among other contributing factors, implementing novel therapies has likely been efficacious outside the clinical trial setting. Still, most men diagnosed with...

ejcancer.com
3
5
1
18
1,149
Great day with Danish dentists discussing prostate cancer, osteoporosis, osteonecrosis of the jaw and bone protective agents. @Tandlaegerne
12
360
We are grateful to be part of this consortium ⁦@KariStefans⁩ ⁦@SisseOstrowski⁩. Congrats to all involved and looking forward to more studies. Stay tuned for some focused on prostate cancer! ⁦@andreasroder1⁩ ⁦⁦@UrologicalRunit⁩ nature.com/articles/s41588-0…
1
2
7
237
Saw a guy who underwent RP 16 yrs ago for pT2cNx, marg-, ISUP2, had 13 years of consecutive undetectable PSAs, then 0.1 in year 14, 0.2 in year 15, now rapidly rising in year 16 with PSAdt<5 mths. Are The Norns playing with us @TylerSbrt ?? #norsemythology
3
3
1,361
Outcomes of iPCa in Denmark 36% w GG1 on TURP have MRi/Bx within 5 years 15-year PCM: 8.4% GG1 on TURP, no cancer on follow up Bx = low PCM, GG2 on follow up Bx = high PCM. @LeniRiccardo @andreasroder1 @VickersBiostats @Albert0Briganti @JUrology auajournals.org/doi/10.1097/…

Management and Oncologic Outcomes of Incidental Prostate Cancer After Transurethral Resection of...

Purpose:Approximately 1 in 10 patients without prior prostate biopsy undergoing surgery for lower urinary tract symptoms harbors incidental prostate cancer; however, practice guidelines do not...

auajournals.org
3
8
381
Letters to the Editor: Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging–visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. buff.ly/3Ts389w By @HeinStroomberg, Klaus Brasso and @andreasroder1 Read the full letter here: buff.ly/3ZklOvy Make sure to check back later to read the reply by the authors! #UroSoMe #MedTwitter #EurUrol #LetterstotheEditor
1
3
5
1,061
This crazy guy @TylerSbrt flies to Copenhagen with an email stating: ‘We have to run a half marathon’. So we did. Absolutely impressed by the energy. More fun coming up tomorrow
1
1
22
2,012
Andreas Røder retweeted
Riccardo Leni@LeniRiccardo20 Aug 2024
#DanProst study -Incidental #PCa mortality can be high (also for #GG1) -Likely due to unsampled PZ #GG2+ -Negative followup #Bx = low #PCSM THM: further assess #iPCa pts, how? @HeinStroomberg @VickersBiostats @andreasroder1 @Albert0Briganti @JUrology pubmed.ncbi.nlm.nih.gov/3908…
3
13
576
Read our cool new story on a surprising therapy response in glioblastoma, led by the very talented @josephinedh1 @UCPH_BRIC @Rigshospitalet 👇
Josephine Deleuran Hendriksen@josephinedh120 Jun 2024
How does glioblastoma cells react to immunotherapy? Find out in our new paper in Neuro-Oncology 📄 doi.org/10.1093/neuonc/noae0… Read about the results in SUND news 📣 healthsciences.ku.dk/newsfac… Or listen to Neuro-Oncology The Podcast 🎧 soc-neuro-onc.libsyn.com/imm… (1/5)
1
1
9
963
Latest article from our brilliant student @juliadagnaesh. In this article she looked at surgical complications following renal transplantation and found short term complications in 60% of the patients. doi.org/10.1097/TXD.00000000… @andreasroder1 @GKristensen01 @HeinStroomberg
2
5
226
We are proud to have contributed to the Radicals study and happy to share these publications: doi.org/10.1016/j.annonc.202… doi.org/10.1016/S0140-6736(2… doi.org/10.1016/S0140-6736(2… Thanks to all the patients, nurses and MDs that contributed. @karinaklovgaard @andreasroder1 @PCaParker
4
6
465
Interactive and thought-provoking talk from @LambAlastair eloquently discussing the evidence for LATP biopsy. Wise words “What is equipoise? Maintaining equivalence when speaking to our patients when the the level of evidence is equivocal.” #ipmasterclass24 – at London, England
8
1
18
3,457
We welcome back on stage the formidable @VickersBiostats Has the use of MRI actually led to overtreatment? We’ve adapted the diagnostic pathway but not adapted our downstream treatment protocols #ipmasterclass24
4
7
25
3,484
Would you go back to your Nokia when you have an iPhone? Or back to Hubble from Webb? Another excellent talk from @andreasroder1 urging caution in changing our treatment decisions based on PSMA PET #ipmasterclass24 Someone buy Prof Røder a new bike! – at London, England
1
9
18
1,301
Andreas Røder retweeted
Torath Ameen@torathameen19 Apr 2024
Great first day of Prostate Focal Therapy at the Imperial Prostate Masterclass 2024 and of note; brilliant and entertaining talks from many speakers including @andreasroder1 @imperialurology @LondonProstate1 @TaimurShah
1
5
17
1,781
Our PhD student Milla Ortved presented her exciting trial comparing open vs. robotic kidney transplantation surgery at the #EAU24 in Paris. You did so well! And we are all looking forward to seeing your results coming up 💪
3
9
655
Load more